Homocyst(e)ine and Risk of Cardiovascular Disease in the Multiple Risk Factor Intervention Trial
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
A nested case-control study was undertaken involving men participating in the Multiple Risk Factor Intervention Trial (MRFIT). Serum samples from 712 men, stored for up to 20 years, were analyzed for homocyst(e)ine. Cases involved nonfatal myocardial infarctions (MIs), identified through the active phase of the study, which ended on February 28, 1982, and deaths due to coronary heart disease (CHD), monitored through 1990. The nonfatal MIs occurred within 7 years of sample collection, whereas the majority of CHD deaths occurred more than 11 years after sample collection. Mean homocyst(e)ine concentrations were in the expected range and did not differ significantly between case patients and control subjects: MI cases, 12.6 μmol/L; MI controls, 13.1 μmol/L; CHD death cases, 12.8 μmol/L; and CHD controls, 12.7 μmol/L. Odds ratios versus quartile 1 for CHD deaths and MIs combined were as follows: quartile 2, 1.03; quartile 3, 0.84; and quartile 4, 0.92. Thus, in this prospective study, no association of homocyst(e)ine concentration with heart disease was detected. Homocyst(e)ine levels were weakly associated with the acute-phase protein (C-reactive protein). These results are discussed with respect to the suggestion that homocyst(e)ine is an independent risk factor for heart disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Frosst, P., Blom, H. J., Milos, R., Goyette, P., Sheppard, C. A., Matthews, R. G., Boers, G. J. H., den Heijer, M., Kluijtmans, L. A. J., van den Heuve, L. P., et al. (1995) · Nature Genetics · doi:10.1038/ng0595-111 · Cited by 5,653
Boushey, C. J. (1995) · JAMA · doi:10.1001/jama.1995.03530130055028 · Cited by 3,584
Hyperhomocysteinemia: An Independent Risk Factor for Vascular Disease
Clarke, R., Daly, L., Robinson, K., Naughten, E., Cahalane, S., Fowler, B., & Graham, I. (1991) · New England Journal of Medicine · doi:10.1056/nejm199104253241701 · Cited by 2,161
Vitamin Status and Intake as Primary Determinants of Homocysteinemia in an Elderly Population
Selhub, J. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510220049033 · Cited by 1,972
Multiple Risk Factor Intervention Trial: Risk Factor Changes and Mortality Results
(1982) · JAMA · doi:10.1001/jama.1982.03330120023025 · Cited by 1,722
A Prospective Study of Plasma Homocyst(e)ine and Risk of Myocardial Infarction in US Physicians
Stampfer, M. J. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03490070059042 · Cited by 1,709
Association between Plasma Homocysteine Concentrations and Extracranial Carotid-Artery Stenosis
Selhub, J., Jacques, P. F., Bostom, A. G., D'Agostino, R. B., Wilson, P. W. F., Belanger, A. J., O'Leary, D. H., Wolf, P. A., Schaefer, E. J., & Rosenberg, I. H. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502023320502 · Cited by 1,216
Relation of C-Reactive Protein and Coronary Heart Disease in the MRFIT Nested Case-Control Study
for the MRFIT Research Group, Kuller, L. H., Tracy, R. P., Shaten, J., & Meilahn, E. N. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008963 · Cited by 1,097
Self-citationHyperhomocysteinemia as a Risk Factor for Deep-Vein Thrombosis
den Heijer, M., Koster, T., Blom, H. J., Bos, G. M. J., Briët, E., Reitsma, P. H., Vandenbroucke, J. P., & Rosendaal, F. R. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603213341203 · Cited by 1,044
Total Plasma Homocysteine and Cardiovascular Risk Profile: The Hordaland Homocysteine Study
Nygård, O., Vollset, S. E., Refsum, H., Stensvold, I., Tverdal, A., Nordrehaug, J. E., Ueland, P. M., & Kvåle, G. (1995) · JAMA · doi:10.1001/jama.1995.03530190040032 · Cited by 1,042
Perry, I. J., Morris, R. W., Ebrahim, S. B., Shaper, A. G., Refsum, H., & Ueland, P. M. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92407-8 · Cited by 883
Stamler, J. S., Osborne, J. A., Jaraki, O., Rabbani, L. E., Mullins, M., Singel, D., & Loscalzo, J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116187 · Cited by 860
Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis.
Tsai, J. C., Perrella, M. A., Yoshizumi, M., Hsieh, C. M., Haber, E., Schlegel, R., & Lee, M. E. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.14.6369 · Cited by 798
Homocysteine and vascular disease
McCully, K. S. (1996) · Nature Medicine · doi:10.1038/nm0496-386 · Cited by 702
Serum Total Homocysteine and Coronary Heart Disease
ARNESEN, E., REFSUM, H., BØNAA, K. H., UELAND, P. M., FØRDE, O. H., & NORDREHAUG, J. E. (1995) · International Journal of Epidemiology · doi:10.1093/ije/24.4.704 · Cited by 651
Alfthan, G., Pekkanen, J., Jauhiainen, M., Pitkäniemi, J., Karvonen, M., Tuomilehto, J., Salonen, J. T., & Ehnholm, C. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90078-7 · Cited by 527
Homocysteine and coronary atherosclerosis
Mayer, E. L., Jacobsen, D. W., & Robinson, K. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00508-0 · Cited by 519
Verhoef, P., Stampfer, M. J., Buring, J. F., Gaziano, J. M., Allen, R. H., Stabler, S. P., Reynolds, R. D., Kok, F. J., Hennekens, C. H., & Willett, W. C. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008828 · Cited by 480
Malinow, M. R., Nieto, F. J., Szklo, M., Chambless, L. E., & Bond, G. (1993) · Circulation · doi:10.1161/01.cir.87.4.1107 · Cited by 451
Jacobsen, D. W., Gatautis, V. J., Green, R., Robinson, K., Savon, S. R., Secic, M., Ji, J., Otto, J. M., & Taylor, L. M. (1994) · Clinical Chemistry · doi:10.1093/clinchem/40.6.873 · Cited by 435
Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus
Petri, M., Roubenoff, R., Dallal, G. E., Nadeau, M. R., Selhub, J., & Rosenberg, I. H. (1996) · The Lancet · doi:10.1016/s0140-6736(96)03032-2 · Cited by 419
Robinson, K., Mayer, E. L., Miller, D. P., Green, R., van Lente, F., Gupta, A., Kottke-Marchant, K., Savon, S. R., Selhub, J., Nissen, S. E., et al. (1995) · Circulation · doi:10.1161/01.cir.92.10.2825 · Cited by 390
A prospective study of plasma homocyst(e)ine and risk of ischemic stroke.
Verhoef, P., Hennekens, C. H., Malinow, M. R., Kok, F. J., Willett, W. C., & Stampfer, M. J. (1994) · Stroke · doi:10.1161/01.str.25.10.1924 · Cited by 379
Fryer, R. H., Wilson, B. D., Gubler, D. B., Fitzgerald, L. A., & Rodgers, G. M. (1993) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.13.9.1327 · Cited by 314
Serum Folate and Risk of Fatal Coronary Heart Disease
Morrison, H. I. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03530480035037 · Cited by 308
Plasma homocyst(e)ine levels in men with premature coronary artery disease
Genest, J. J., McNamara, J. R., Salem, D. N., Wilson, P. W. F., Schaefer, E. J., & Malinow, M. R. (1990) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(90)90542-w · Cited by 296
A prospective study of folate and vitamin B6 and risk of myocardial infarction in US physicians.
Chasan-Taber, L., Selhub, J., Rosenberg, I. H., Malinow, M. R., Terry, P., Tishler, P. V., Willett, W., Hennekens, C. H., & Stampfer, M. J. (1996) · Journal of the American College of Nutrition · doi:10.1080/07315724.1996.10718578 · Cited by 273
Homocyst(e)ine and arterial occlusive diseases
MALINOW, M. R. (1994) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1994.tb00854.x · Cited by 247
Homocysteine and Risk of Premature Coronary Heart Disease: Evidence for a Common Gene Mutation
Gallagher, P. M., Meleady, R., Shields, D. C., Tan, K. S., McMaster, D., Rozen, R., Evans, A., Graham, I. M., & Whitehead, A. S. (1996) · Circulation · doi:10.1161/01.cir.94.9.2154 · Cited by 236
Fermo, I., D'Angelo, S. V., Paroni, R., Mazzola, G., Calori, G., & D'Angelo, A. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-10-199511150-00002 · Cited by 225
Plasma Homocysteine in the Acute and Convalescent Phases After Stroke
Lindgren, A., Brattström, L., Norrving, B., Hultberg, B., Andersson, A., & Johansson, B. B. (1995) · Stroke · doi:10.1161/01.str.26.5.795 · Cited by 216
Kuller, L. H., Eichner, J. E., Orchard, T. J., Grandits, G. A., McCallum, L., Tracy, R. P., & for the Multiple Risk Factor Intervention Trial Research Group (1991) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116030 · Cited by 199
Self-citationGuttormsen, A. B., Schneede, J., Fiskerstrand, T., Ueland, P. M., & Refsum, H. M. (1994) · The Journal of Nutrition · doi:10.1093/jn/124.10.1934 · Cited by 191
Homocysteine metabolism and the oxidative modification of proteins and lipids
Olszewski, A. J., & McCully, K. S. (1993) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(93)90151-j · Cited by 168
Multiple Risk Factor Intervention Trial Research Group (1986) · Preventive Medicine · doi:10.1016/0091-7435(86)90045-9 · Cited by 148
Plasma homocysteine and cardiovascular disease mortality
Alfthan, G., Aro, A., & GEY, K. F. (1997) · The Lancet · doi:10.1016/s0140-6736(97)80014-1 · Cited by 144
von Eckardstein, A., Malinow, M. R., Upson, B., Heinrich, J., Schulte, H., Schönfeld, R., Köhler, E., & Assmann, G. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.3.460 · Cited by 141
Malinow, M. R., Levenson, J. A., Giral, P., Nieto, F. J., Razavian, M., Segond, P., & Simon, A. C. (1995) · Atherosclerosis · doi:10.1016/0021-9150(94)05481-w · Cited by 137
Genetic Polymorphism of Methylenetetrahydrofolate Reductase and Myocardial Infarction
Schmitz, C., Lindpaintner, K., Verhoef, P., Gaziano, J. M., & Buring, J. E. (1996) · Circulation · doi:10.1161/01.cir.94.8.1812 · Cited by 134
Serial measures of plasma homocyst(e)ine after acute myocardial infarction
Egerton, W., Silberberg, J. S., Crooks, R., Ray, C. D., Xie, L., & Dudman, N. P. B. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)89213-2 · Cited by 125
Giles, W. H., Kittner, S. J., Anda, R. F., Croft, J. B., & Casper, M. L. (1995) · Stroke · doi:10.1161/01.str.26.7.1166 · Cited by 123
Anker, G., Lonning, P. E., Ueland, P. M., Refsum, H., & Lien, E. A. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910600316 · Cited by 110
Effects of Caffeine on Analgesia from Transcutaneous Electrical Nerve Stimulation
Marchand, S., Li, J., & Charest, J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508033330521 · Cited by 79
Israelsson, B., Brattström, L. E., & Refsum, H. (1993) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365519309092541 · Cited by 60
Prospective Studies of Homocysteine and Cardiovascular Disease
Verhoef, P., & Stampfer, M. J. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1995.tb01478.x · Cited by 58
Plasma Homocyst(e)ine or Homocysteine?
Mudd, S. H., & Levy, H. L. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508033330520 · Cited by 49
de Valk, H. W., van Eeden, M. K. G., Banga, J. D., van der Griend, R., de Groot, E., Haas, F. J. L. M., Meuwissen, O. J., Durán, M., Smeitink, J. A. M., Poll‐The, B. T., et al. (1996) · PubMed · Cited by 17
Cited by
Homocysteine and Risk of Ischemic Heart Disease and Stroke: A Meta-analysis
Homocysteine Studies Collaboration (2002) · JAMA · doi:10.1001/jama.288.16.2015 · Cited by 2,059
“The risks of IHD associated with given differences in homocysteine level observed in the prospective studies of such individuals were remarkably consistent, with the exception of the Multiple Risk Factor Intervention Trial.(13) The reasons for the apparent discrepancy in that study are unclear, although the mean time…”
BackgroundResultInfluentialKrauss, R. M., Eckel, R. H., Howard, B., Appel, L. J., Daniels, S. R., Deckelbaum, R. J., Erdman, J. W., Kris-Etherton, P., Goldberg, I. J., Kotchen, T. A., et al. (2000) · Circulation · doi:10.1161/01.cir.102.18.2284 · Cited by 1,458
Ridker, P. M. (2001) · Circulation · doi:10.1161/01.cir.103.13.1813 · Cited by 1,402
Wood, D., De Backer, G., Faergeman, O., Graham, I., Mancia, G., & Pyörälä, K. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)90209-x · Cited by 1,255
Jellinger, P. S., Handelsman, Y., Rosenblit, P. D., Bloomgarden, Z. T., Fonseca, V. A., Garber, A. J., Grunberger, G., Guerin, C. K., Bell, D. S. H., Mechanick, J. I., et al. (2017) · Endocrine Practice · doi:10.4158/ep171764.appgl · Cited by 1,094
Metadata
- Authors
- Evans, R. W., Shaten, B. J., Hempel, J. D., Cutler, J. A., & Kuller, L. H.
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 1997-10
- Volume
- 17
- Issue
- 10
- Pages
- 1947-1953
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2134979646
- Cited by
- 342
- References
- 47
- FWCI
- 26.14
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.